Health and Healthcare
GlaxoSmithKline Continues Down A Dangerous Path
Published:
Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks.
According to The Wall Street Journal "the Food and Drug Administration is considering whether Avandia’s use should be restricted." Studies show that the drug can increase risk of heart attack. In a research paper form Wake Forest University doctors found that patients taking Avandia had a 42% greater chance of having a heart attack than those in the control group.
The whole incident begs that question of what major drug companies never take their own products off the market when there is overwhelming evidence that they create health risk. There must be some actuary who works out the balance between profit and potential liability if court cases for wrongful death begin to emerge.
Of course, that leaves out the question of ethics.
Douglas A. McIntyre
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
